Treatment Effectiveness
User reported effectiveness ratings Baclofen for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Chronic Fatigue Syndrome | 11% | 30% | 7% | 44% | 7% | 27 |
| Fibromyalgia | 100% | 0% | 0% | 0% | 0% | 1 |
| Migraine | 5% | 20% | 8% | 63% | 5% | 40 |
| Multiple Sclerosis | 16% | 24% | 3% | 46% | 11% | 79 |
| Neurological Problems and Chronic Pain | 12% | 44% | 12% | 20% | 12% | 25 |
| Neuropathy | 0% | 47% | 20% | 33% | 0% | 15 |
Side Effects
User-reported side effects of Baclofen
| Side Effect | Percent of Reports Baclofen |
|---|---|
| Confusion | 20% |
| Dizziness | 33% |
| Drowsiness | 60% |
| Thrush | 0% |
| Upset Stomach | 18% |
| Weakness | 36% |
| Insomnia | 18% |
Outcomes
Below is the degree of change seen after Baclofen is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Baclofen Info
| Property | Value |
|---|---|
| Variable Name | Baclofen |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-07 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Mean | 10 count |
| Median | 10 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 1 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 1 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0 |
| Unit | Count |
| User Variables | 1 |
| UPC | 052301303250 |
| Variable Category | Treatments |
| Variable ID | 92607 |
| Variance | 0 |